TELA Bio, Inc. TELA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -41.18M | -39.84M | -38.83M | -39.00M | -40.77M |
| Total Depreciation and Amortization | 1.00M | 1.01M | 1.01M | 1.05M | 1.07M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.11M | 8.30M | 8.11M | 7.77M | 7.56M |
| Change in Net Operating Assets | 928.00K | 869.00K | 1.50M | -702.00K | -2.00M |
| Cash from Operations | -31.14M | -29.66M | -28.22M | -30.88M | -34.14M |
| Capital Expenditure | -480.00K | -535.00K | -448.00K | -621.00K | -532.00K |
| Sale of Property, Plant, and Equipment | 1.41M | 1.43M | 1.29M | 1.09M | 562.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 933.00K | 898.00K | 846.00K | 464.00K | 30.00K |
| Total Debt Issued | 60.00M | 60.00M | 60.00M | -- | -- |
| Total Debt Repaid | -42.42M | -42.42M | -42.42M | -- | -- |
| Issuance of Common Stock | 11.90M | 11.90M | 11.93M | 43.03M | 43.10M |
| Repurchase of Common Stock | -119.00K | -107.00K | -205.00K | -212.00K | -210.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.80M | -3.80M | -3.55M | -- | -- |
| Cash from Financing | 25.56M | 25.57M | 25.75M | 42.81M | 42.89M |
| Foreign Exchange rate Adjustments | 33.00K | -109.00K | -217.00K | 0.00 | -292.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.62M | -3.31M | -1.84M | 12.40M | 8.48M |